WOBURN, MA / ACCESSWIRE / May 15, 2023 / Biofrontera Inc. (Nasdaq:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, announces that the ...
Announcing a new publication for Acta Materia Medica journal. Treatment of cancer can be challenging, because of the disease’s intricate and varied nature. Consequently, developing nanomedicines with ...
12don MSN
Photodynamic therapy technique deactivates tumors from within, using clinically approved agents
Researchers at the Madrid Institute for Advanced Studies in Nanoscience (IMDEA Nanociencia) and the National Center for ...
A new publication from Opto-Electronic Advances; DOI 10.29026/oea.2024.240013, discusses a NIR-triggered on-site NO/ROS/RNS nanoreactor. Phototherapy is a safe and effective method for tumor treatment ...
Novel Protocol is Expected to be Less Painful with Efficacy Similar to Conventional PDT WOBURN, MA / ACCESSWIRE / May 15, 2023 / Biofrontera Inc. (Nasdaq:BFRI) (the "Company"), a biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback